PDP-Miner: an AI/ML tool to detect prophage tail proteins with depolymerase domains across thousands of bacterial

Jeff Gauthier1,2, Irena Kukavica-Ibrulj1,2, Roger C Levesque1,2

  • 1Institut de Biologie Intégrative et des Systèmes, Université Laval, Québec, QC, G1V 0A6, Canada.

PubMed
Abstract

Insights

Phage tail proteins are a promising alternative to antibiotics. PDP-Miner identifies potential depolymerase genes in Pseudomonas genomes, aiding in the fight against antibiotic resistance.

Area of Science:

  • Microbiology
  • Bioinformatics
  • Genomics

Background:

  • Antibiotic resistance is a growing global health crisis, with no new major antibiotic classes approved since 1987.
  • Phage tail proteins, particularly depolymerases targeting bacterial outer membrane polysaccharides, represent a promising alternative therapeutic strategy.
  • Pathogenic bacteria often harbor prophages, providing known molecular targets for phage-derived therapies.

Purpose of the Study:

  • To develop a computational tool for identifying phage depolymerase genes.
  • To annotate and detect depolymerase activity in phage tail proteins.
  • To validate potential depolymerase candidates by analyzing protein domains.

Main Methods:

  • Developed PDP-Miner, a wrapper for the machine learning-based Depolymerase-Predictor tool.
  • Annotated phage tail proteins ab initio and detected depolymerase activity.
  • Performed post-hoc validation by annotating protein domains for depolymerase indicators.

Main Results:

  • Identified 10 high-confidence phage depolymerase gene candidates in 1,294 Pseudomonas genomes from the International Pseudomonas Consortium Database.
  • Accurately reported depolymerases in known phage genomes.
  • Demonstrated comparable performance to existing tools like PhageDPO and DepoScope.

Conclusions:

  • PDP-Miner is an effective tool for identifying novel phage depolymerase candidates.
  • The tool aids in the discovery of potential antimicrobial agents to combat antibiotic resistance.
  • Facilitates the investigation of phage proteins for therapeutic applications.